Table 3.
Systemic symptoms during SARS-CoV-2 infection in patients with uveitis.
| Symptom/Degree | None | Slight | Moderate | Serious | Severe |
|---|---|---|---|---|---|
| Generalized pain | 49(43.0%) | 24(21.1%) | 23(20.2%) | 16(14.0%) | 2(1.8%) |
| Weakness | 39(34.2%) | 25(21.9%) | 32(28.1%) | 14(12.3%) | 4(3.5%) |
| Pharyngeal pain | 46(40.4%) | 30(26.3%) | 21(18.4%) | 11(9.6%) | 6(5.3%) |
| Cough | 30(26.3%) | 32(28.1%) | 37(32.5%) | 13(11.4%) | 3(2.6%) |
| Dyspnea | 94(82.5%) | 15(13.2%) | 5(4.4%) | 0(0%) | 0(0%) |
| Blood oxygen desaturation | 111(97.4%) | 2(1.8%) | 1(0.9%) | 0(0%) | 0(0%) |
| Diarrhoea | 98(86.0%) | 9(7.9%) | 3(2.6%) | 4(3.5%) | 0(0%) |
| Vomit | 101(88.6%) | 4(3.5%) | 7(6.1%) | 1(0.9%) | 1(0.9%) |
| Loss of the sense of smell or taste | 71(62.3%) | 19(16.7%) | 15(13.2%) | 5(4.4%) | 4(3.5%) |